PROSTAPHLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prostaphlin, and what generic alternatives are available?
Prostaphlin is a drug marketed by Apothecon and is included in two NDAs.
The generic ingredient in PROSTAPHLIN is oxacillin sodium. There are thirty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the oxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prostaphlin
A generic version of PROSTAPHLIN was approved as oxacillin sodium by SAGENT PHARMS on March 30th, 2012.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROSTAPHLIN?
- What are the global sales for PROSTAPHLIN?
- What is Average Wholesale Price for PROSTAPHLIN?
Summary for PROSTAPHLIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 25 |
| Patent Applications: | 4,254 |
| DailyMed Link: | PROSTAPHLIN at DailyMed |
US Patents and Regulatory Information for PROSTAPHLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | PROSTAPHLIN | oxacillin sodium | CAPSULE;ORAL | 050118-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Apothecon | PROSTAPHLIN | oxacillin sodium | FOR SOLUTION;ORAL | 050194-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
